Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comprehensive review of mechanisms of pathogenesis involved in Alzheimer’s disease and potential therapeutic strategies
Piyoosh Sharma, Pavan Srivastava, Ankit Seth, et al.
Progress in Neurobiology (2018) Vol. 174, pp. 53-89
Closed Access | Times Cited: 285

Showing 1-25 of 285 citing articles:

A Perspective on Multi-target Drugs for Alzheimer’s Disease
Ondřej Benek, Jan Korábečný, Ondřej Soukup
Trends in Pharmacological Sciences (2020) Vol. 41, Iss. 7, pp. 434-445
Closed Access | Times Cited: 204
Alzheimer’s Disease: An Updated Overview of Its Genetics
Jesús Andrade-Guerrero, Alberto Santiago-Balmaseda, Paola Jeronimo-Aguilar, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3754-3754
Open Access | Times Cited: 171
Toxicology and pharmacology of synthetic organoselenium compounds: an update
Cristina W. Nogueira, Nilda Vargas Barbosa, João Batista Teixeira da Rocha
Archives of Toxicology (2021) Vol. 95, Iss. 4, pp. 1179-1226
Open Access | Times Cited: 166
Emerging role of gut microbiota in modulation of neuroinflammation and neurodegeneration with emphasis on Alzheimer's disease
Divya Goyal, Syed Afroz Ali, Rakesh Kumar Singh
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 106, pp. 110112-110112
Closed Access | Times Cited: 164
Altered glucose metabolism in Alzheimer's disease: Role of mitochondrial dysfunction and oxidative stress
Saikat Dewanjee, Pratik Chakraborty, Hiranmoy Bhattacharya, et al.
Free Radical Biology and Medicine (2022) Vol. 193, pp. 134-157
Closed Access | Times Cited: 127
Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies
Jifa Zhang, Yinglu Zhang, Jiaxing Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 114
Exosomes based strategies for brain drug delivery
Fawad Ur Rehman, Yang Liu, Meng Zheng, et al.
Biomaterials (2022) Vol. 293, pp. 121949-121949
Closed Access | Times Cited: 108
Salidroside Ameliorates Alzheimer's Disease by Targeting NLRP3 Inflammasome-Mediated Pyroptosis
Yawen Cai, Yuhui Chai, Yu Fu, et al.
Frontiers in Aging Neuroscience (2022) Vol. 13
Open Access | Times Cited: 88
Cognitive enhancement and neuroprotective effects of OABL, a sesquiterpene lactone in 5xFAD Alzheimer's disease mice model
Jiang‐Jiang Tang, Lan-Fang Huang, Jiale Deng, et al.
Redox Biology (2022) Vol. 50, pp. 102229-102229
Open Access | Times Cited: 76
Review of Pharmacotherapeutic Targets in Alzheimer’s Disease and Its Management Using Traditional Medicinal Plants
Prabhash Nath Tripathi, Ankit Lodhi, Sachchida Nand, et al.
Degenerative Neurological and Neuromuscular Disease (2024) Vol. Volume 14, pp. 47-74
Open Access | Times Cited: 44
Bioactivity, cytotoxicity, and molecular modeling studies of novel sulfonamides as dual inhibitors of carbonic anhydrases and acetylcholinesterase
Özcan Güleç, Cüneyt Türkeş, Mustafa Arslan, et al.
Journal of Molecular Liquids (2024) Vol. 410, pp. 125558-125558
Closed Access | Times Cited: 26
Exercise-Induced Reduction of IGF1R Sumoylation Attenuates Neuroinflammation in APP/PS1 Transgenic Mice
Yisheng Chen, Xiaofeng Chen, Zhiwen Luo, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 18
Antioxidant and Anti-inflammatory Mechanisms of Neuroprotection by Ursolic Acid: Addressing Brain Injury, Cerebral Ischemia, Cognition Deficit, Anxiety, and Depression
Solomon Habtemariam
Oxidative Medicine and Cellular Longevity (2019) Vol. 2019, pp. 1-18
Open Access | Times Cited: 125
Design and development of multitarget-directed N-Benzylpiperidine analogs as potential candidates for the treatment of Alzheimer's disease
Piyoosh Sharma, Avanish Tripathi, Prabhash Nath Tripathi, et al.
European Journal of Medicinal Chemistry (2019) Vol. 167, pp. 510-524
Closed Access | Times Cited: 93
Improving Drug Delivery for Alzheimer’s Disease Through Nose-to-Brain Delivery Using Nanoemulsions, Nanostructured Lipid Carriers (NLC) and in situ Hydrogels
Sara Cunha, Ben Forbes, José Manuel Sousa Lobo, et al.
International Journal of Nanomedicine (2021) Vol. Volume 16, pp. 4373-4390
Open Access | Times Cited: 92
High-resolution mapping of brain vasculature and its impairment in the hippocampus of Alzheimer's disease mice
Xiaochuan Zhang, Xianzhen Yin, Jingjing Zhang, et al.
National Science Review (2019) Vol. 6, Iss. 6, pp. 1223-1238
Open Access | Times Cited: 88
FA-97, a New Synthetic Caffeic Acid Phenethyl Ester Derivative, Protects against Oxidative Stress-Mediated Neuronal Cell Apoptosis and Scopolamine-Induced Cognitive Impairment by Activating Nrf2/HO-1 Signaling
Ting Wan, Zihao Wang, Yi Luo, et al.
Oxidative Medicine and Cellular Longevity (2019) Vol. 2019, pp. 1-21
Open Access | Times Cited: 85
The Role of Selected Bioactive Compounds in the Prevention of Alzheimer’s Disease
Wojciech Grodzicki, Katarzyna Dziendzikowska
Antioxidants (2020) Vol. 9, Iss. 3, pp. 229-229
Open Access | Times Cited: 80
Biomaterials in Neurodegenerative Disorders: A Promising Therapeutic Approach
Matteo Bordoni, Eveljn Scarian, Federica Rey, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3243-3243
Open Access | Times Cited: 80
A review on ferulic acid and analogs based scaffolds for the management of Alzheimer’s disease
Yash Pal Singh, Himanshu Rai, Gourav Singh, et al.
European Journal of Medicinal Chemistry (2021) Vol. 215, pp. 113278-113278
Closed Access | Times Cited: 77
Machine Learning Algorithms and Statistical Approaches for Alzheimer’s Disease Analysis Based on Resting-State EEG Recordings: A Systematic Review
Katerina D. Tzimourta, Vasileios Christou, Alexandros T. Tzallas, et al.
International Journal of Neural Systems (2021) Vol. 31, Iss. 05, pp. 2130002-2130002
Closed Access | Times Cited: 66
Detection of multiplex exosomal miRNAs for clinically accurate diagnosis of Alzheimer’s disease using label-free plasmonic biosensor based on DNA-Assembled advanced plasmonic architecture
Sojin Song, Jong Uk Lee, Myeong Jin Jeon, et al.
Biosensors and Bioelectronics (2021) Vol. 199, pp. 113864-113864
Closed Access | Times Cited: 65
Bioactive Compounds and Their Derivatives: An Insight into Prospective Phytotherapeutic Approach against Alzheimer’s Disease
Fahadul Islam, Jannatul Fardous Khadija, Md. Harun-Or-Rashid, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-22
Open Access | Times Cited: 59
Research progress of multi-functional fluorescent probes for Alzheimer's disease monitoring
Jinrong Yang, Yuhui Guo, Marco Pistolozzi, et al.
Dyes and Pigments (2021) Vol. 193, pp. 109466-109466
Closed Access | Times Cited: 56
Near-Infrared Fluorescent Probes as Imaging and Theranostic Modalities for Amyloid-Beta and Tau Aggregates in Alzheimer’s Disease
Himanshu Rai, Sarika Gupta, Saroj Kumar, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 13, pp. 8550-8595
Closed Access | Times Cited: 51
Page 1 - Next Page

Scroll to top